Cargando…

Efficacy and safety of oral robenacoxib (tablet) for the treatment of pain associated with soft tissue surgery in client-owned dogs

BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) have been proven to be effective in controlling peri-operative pain in dogs. Robenacoxib is an NSAID with high selectivity for the cyclooxygenase (COX)-2 isoform. The objective of this study was to assess the efficacy and safety of an oral t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Friton, Gabriele, Thompson, Caryn Marie, Karadzovska, Daniela, King, Stephen, King, Jonathan N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485494/ https://www.ncbi.nlm.nih.gov/pubmed/28651573 http://dx.doi.org/10.1186/s12917-017-1100-x

Ejemplares similares

Efficacy and Safety of Injectable Robenacoxib for the Treatment of Pain Associated With Soft Tissue Surgery in Dogs
por: Friton, G., et al.
Publicado: (2017)

Clinical safety of robenacoxib in cats with chronic musculoskeletal disease
por: King, Jonathan N., et al.
Publicado: (2021)

Six-month safety evaluation of robenacoxib tablets (Onsior™) in dogs after daily oral administrations
por: Toutain, Céline E., et al.
Publicado: (2018)

Safety evaluation of the interchangeable use of robenacoxib (Onsior™) tablets and solution for injection in dogs
por: Toutain, Céline E., et al.
Publicado: (2017)

Safety evaluation of the interchangeable use of robenacoxib in commercially-available tablets and solution for injection in cats
por: Heit, Mark C., et al.
Publicado: (2020)

Effect of benazepril, robenacoxib and their combination on glomerular filtration rate in cats
por: King, Jonathan N., et al.
Publicado: (2016)

A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA
por: Karadzovska, Daniela, et al.
Publicado: (2017)

A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™ CAT) in eliminating fleas in client-owned cats in the USA
por: Chappell, Kimberly, et al.
Publicado: (2021)

Robenacoxib in the treatment of pain in cats and dogs: safety, efficacy, and place in therapy
por: Kongara, Kavitha, et al.
Publicado: (2018)

Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis
por: Visser, Marike, et al.
Publicado: (2022)

Robenacoxib versus meloxicam for the management of pain and inflammation associated with soft tissue surgery in dogs: a randomized, non-inferiority clinical trial
por: Gruet, Philippe, et al.
Publicado: (2013)

Evaluation of Oral Robenacoxib for the Treatment of Postoperative Pain and Inflammation in Cats: Results of a Randomized Clinical Trial
por: King, Stephen, et al.
Publicado: (2012)

Pharmacology, safety, efficacy and clinical uses of the COX‐2 inhibitor robenacoxib
por: Lees, Peter, et al.
Publicado: (2022)

A randomised, blinded, controlled field study to assess the efficacy and safety of lotilaner tablets (Credelio™) in controlling fleas in client-owned dogs in European countries
por: Cavalleri, Daniela, et al.
Publicado: (2017)

Evaluation of injectable robenacoxib for the treatment of post-operative pain in cats: results of a randomized, masked, placebo-controlled clinical trial
por: King, Stephen, et al.
Publicado: (2016)

Safety and efficacy of a novel oral chewable combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea infestations in client-owned dogs in the USA
por: Kryda, Kristina, et al.
Publicado: (2020)

Robenacoxib pharmacokinetics in sheep following oral, subcutaneous, and intravenous administration
por: Fadel, Charbel, et al.
Publicado: (2022)

A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs
por: Little, Peter R, et al.
Publicado: (2015)

Vaccine‐Associated Leptospira Antibodies in Client‐Owned Dogs
por: Martin, L.E.R., et al.
Publicado: (2014)

The effect of robenacoxib on the concentration of C-reactive protein in synovial fluid from dogs with osteoarthritis
por: Bennett, David, et al.
Publicado: (2013)

Robenacoxib shows efficacy for the treatment of chronic degenerative joint disease-associated pain in cats: a randomized and blinded pilot clinical trial
por: Adrian, Derek, et al.
Publicado: (2021)

Robenacoxib versus meloxicam for the control of peri-operative pain and inflammation associated with orthopaedic surgery in cats: a randomised clinical trial
por: Speranza, Cindy, et al.
Publicado: (2015)

A randomized, controlled study to assess the efficacy and safety of lotilaner (Credelio™) in controlling ticks in client-owned dogs in Europe
por: Cavalleri, Daniela, et al.
Publicado: (2017)

A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel(®)) in client‐owned dogs with atopic dermatitis
por: Cosgrove, Sallie B., et al.
Publicado: (2013)

Influence of sevoflurane anesthesia with mechanical ventilation and fluid-therapy on distribution of subcutaneously administered robenacoxib in dogs
por: OYAMA, Norihiko, et al.
Publicado: (2018)

Impact of cytidine diphosphocholine on oxygenation in client‐owned dogs with aspiration pneumonia
por: Young, Anda A., et al.
Publicado: (2022)

Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia
por: Gadeyne, Caroline, et al.
Publicado: (2014)

Sparing Effect of Robenacoxib on the Minimum Alveolar Concentration for Blunting Adrenergic Response (MAC-BAR) of Sevoflurane in Dogs
por: TAMURA, Jun, et al.
Publicado: (2013)

Clinical Outcomes of Surgically Managed Spontaneous Tumors in 114 Client-owned Dogs
por: Choi, Ji-Won, et al.
Publicado: (2016)

Association between life span and body condition in neutered client‐owned dogs
por: Salt, Carina, et al.
Publicado: (2018)

Efficacy of orally and topically administered fluralaner (Bravecto(®)) for treatment of client-owned dogs with sarcoptic mange under field conditions
por: Chiummo, Rafael, et al.
Publicado: (2020)

Evaluation of renal values during treatment for heartworm disease in 27 client-owned dogs
por: Vetter, C. Autumn M., et al.
Publicado: (2023)

Vaccination against Extracellular Vimentin for Treatment of Urothelial Cancer of the Bladder in Client-Owned Dogs
por: Engbersen, Diederik J. M., et al.
Publicado: (2023)

Efficacy of lotilaner (Credelio™) against the adult cat flea, Ctenocephalides felis and flea eggs following oral administration to dogs
por: Young, Lisa, et al.
Publicado: (2020)

Evaluation of the Effects of Undenatured Type II Collagen (UC-II) as Compared to Robenacoxib on the Mobility Impairment Induced by Osteoarthritis in Dogs
por: Stabile, Marzia, et al.
Publicado: (2019)

A masked, randomised clinical trial evaluating the efficacy and safety of lokivetmab compared to saline control in client‐owned dogs with allergic dermatitis
por: Van Brussel, Leen, et al.
Publicado: (2021)

Modeling of Large Pharmacokinetic Data Using Nonlinear Mixed‐Effects: A Paradigm Shift in Veterinary Pharmacology. A Case Study With Robenacoxib in Cats
por: Pelligand, L, et al.
Publicado: (2016)

Positive Impact of Nutritional Interventions on Serum Symmetric Dimethylarginine and Creatinine Concentrations in Client-Owned Geriatric Dogs
por: Hall, Jean A., et al.
Publicado: (2016)

Prevalence, type, and prognosis of ocular lesions in shelter and owned-client dogs naturally infected by Leishmania infantum
por: Pietro, Simona Di, et al.
Publicado: (2016)

Prevalence of Neutralizing Antibodies to Canine Distemper Virus and Response to Vaccination in Client-Owned Adult Healthy Dogs
por: Bergmann, Michèle, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jasnpg0stsijjfjbjo8u25890i